TP53 and cancer: While in MDA-MB-231 cells treated with Mel-NIO and olaparib showed non-significant differences between each other in the expression levels of P53 and caspase-3, on the other hand, the expression level of Bax showed non-significant differences between untreated cancer cells and Car-NIO treated cell (Figure 6).